N/A N=10 Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation
Atrial Fibrillation
Primary: Real-time Electrogram Morphology Recurrence (EMR) Mapping Feasibility — 10 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=89 2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation
Atrial Fibrillation
Primary: Number of Patients Atrial Fibrillation — 26; 14 Participants
N/A N=200 TAPP Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh
Postoperative Complications
Primary: Proportion of Subjects Who Experience Hernia Recurrence (Defect Treated Initially With Parietex™ ProGrip™) Within 12 Months Post-surgery. — 3 participants
Phase 1 N=19 Remote-delivered MBCT for SCAD Survivors
Acute Coronary Syndrome · Coronary Artery Disease · Anxiety
Primary: Feasibility of Enrollment: Percent of Participants Enrolled — 19 Participants
N/A N=29 Prenatal Mindfulness & Hypertension Study
Hypertension in Pregnancy
Primary: Retention and Adherence — 12; 11 Participants
Phase 1 N=15 [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
Cancer · Brain Tumors
Primary: Area Under the Receiver Operating Curve (ROC AUC) Values for PET Imaging Techniques — 0.98; 0.91; 0.89; 0.82 Probability
Phase 2 N=39 Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery
Pterygium
Primary: Number of Participants Who Had Recurrence of Pterygia up to 1 Year — 0; 3 participants
N/A N=54 Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial
Bacterial Vaginosis
Primary: Recurrent Bacterial Vaginosis — 7; 7 Participants — p=0.75
Phase 3 N=263 ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection
Clostridioides Difficile Infection
Primary: Cohort 1: Recurrence of CDI and Sustained Clinical Response — 4; 25 Participants
Phase 2 N=29 Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma
Urothelial Carcinoma
Primary: Bladder Tumor Recurrence Rate — 41.37 percentage of subjects
N/A N=20 Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change
Acute Coronary Syndrome · Fear · Medication Adherence
Primary: Change in Total Score for Concerns About Recurrence Scale [Adapted for Acute Coronary Syndrome] — -5.40; -2.86 change in score on a scale — p=0.698
Phase 2 N=132 Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection
Clostridium Difficile Infection · Recurrent Clostridium Difficile Infection · C. Diff
Primary: Number of Participants With Absence of Recurrence Through Week 8 Based on Adjudication — 106 Participants
N/A N=14 Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
Breast Cancer
Primary: Safety — 13 participants
Phase 3 N=815 Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery
Iris Melanoma · Medium/Large Size Posterior Uveal Melanoma · Mucosal Melanoma
Primary: Overall Survival — 69.6; 59.3 months — p=0.528
Phase 4 N=626 MAPS Trial: Matrix And Platinum Science
Intracranial Aneurysms
Primary: Target Aneurysm Recurrence (TAR) Defined as Clinically Relevant Recurrence Resulting in Target Aneurysm Reintervention, Rupture/Re-rupture and/or Death From an Unknown…